Population Pharmacokinetics and Pharmacodynamics of Sitafloxacin in Plasma and Alveolar Epithelial Lining Fluid of Critically Ill Thai Patients With Pneumonia
ABSTRACT Sitafloxacin is one of the oral respiratory quinolones for the treatment of community‐acquired pneumonia. The pharmacokinetic (PK) changes of sitafloxacin in critical illness have been previously reported. However, sitafloxacin exposure and target attainment have never been confirmed in thi...
Saved in:
| Main Authors: | Taniya Paiboonvong, Preecha Montakantikul, Navarat Panjasawatwong, Noppaket Singkham, Baralee Punyawudho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Pharmacology Research & Perspectives |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/prp2.70081 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model-guided development of pharmacokinetic/pharmacodynamic cut-offs and evaluation of sitafloxacin dosing regimens against target pathogens
by: Hailan Wu, et al.
Published: (2025-02-01) -
Antibacterial Mechanisms and Clinical Impact of Sitafloxacin
by: Elian M. A. Kuhn, et al.
Published: (2024-11-01) -
Early bactericidal activity of sitafloxacin against pulmonary tuberculosis
by: Lihui Nie, et al.
Published: (2025-01-01) -
Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial Isolates
by: Zhang J, et al.
Published: (2025-04-01) -
Pharmacokinetic/pharmacodynamic modeling in plasma and milk and Monte Carlo simulations of marbofloxacin against Staphylococcus aureus and Mycoplasma agalactiae in lactating sheep
by: J.M. Serrano-Rodríguez, et al.
Published: (2025-05-01)